Cormorant Asset Management, LP - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 85 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$13,086,000
-51.5%
900,000
-40.0%
0.78%
-29.1%
Q3 2021$27,000,000
-23.1%
1,500,000
-25.0%
1.10%
-8.0%
Q2 2021$35,120,000
-30.3%
2,000,0000.0%1.19%
+6.2%
Q1 2021$50,400,000
+18566.7%
2,000,000
+700.0%
1.12%
+6918.8%
Q3 2019$270,000
-50.7%
250,0000.0%0.02%
-48.4%
Q2 2019$548,000
-78.2%
250,000
-40.6%
0.03%
-81.8%
Q1 2019$2,519,000
-28.7%
420,555
-12.0%
0.17%
-40.8%
Q4 2018$3,533,000
-51.3%
478,055
-4.4%
0.29%
-39.2%
Q3 2018$7,260,000
-30.8%
500,000
-4.9%
0.47%
-39.3%
Q2 2018$10,495,000
+14.0%
525,5380.0%0.78%
+13.3%
Q1 2018$9,207,000
-32.1%
525,538
-4.4%
0.69%
-51.7%
Q4 2017$13,563,000
-4.5%
550,0000.0%1.42%
-43.4%
Q3 2017$14,196,000
-27.3%
550,000
-23.6%
2.51%
-22.6%
Q2 2017$19,526,000
-18.2%
720,000
-10.0%
3.24%
-6.6%
Q1 2017$23,856,000
-10.0%
800,000
-18.1%
3.46%
-3.0%
Q4 2016$26,496,000
+14.8%
976,286
+8.3%
3.57%
+40.4%
Q3 2016$23,082,000
+38.7%
901,2860.0%2.54%
+7.8%
Q2 2016$16,647,000
+35.6%
901,286
+39.1%
2.36%
+27.6%
Q1 2016$12,279,000
-29.7%
647,9440.0%1.85%
-11.4%
Q4 2015$17,456,000647,9442.09%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,769,785$1,911,0000.69%
Telemetry Investments, L.L.C. 214,593$232,0000.67%
Aisling Capital Management LP 634,455$685,0000.36%
Broadfin Capital, LLC 1,620,000$1,750,0000.32%
MFN Partners Management, LP 1,500,000$1,620,0000.24%
Sofinnova Investments, Inc. 1,911,573$2,064,0000.19%
Rock Springs Capital Management LP 2,974,754$3,213,0000.13%
Alambic Investment Management, L.P. 150,636$163,0000.12%
Cormorant Asset Management, LP 250,000$270,0000.02%
Man Group plc 3,734,793$4,034,0000.02%
View complete list of ACLARIS THERAPEUTICS INC shareholders